Company Overview

Cosmos Health Inc. is a diversified healthcare and pharmaceutical company focused on nutraceuticals, pharmaceuticals, over-the-counter health products, telehealth services, and healthcare distribution. The company operates primarily in the healthcare, pharmaceutical distribution, and wellness industries, with activities spanning branded nutraceutical development, pharmaceutical wholesale operations, and healthcare technology services. Revenue is primarily generated through pharmaceutical distribution activities, sales of proprietary nutraceutical and wellness brands, and healthcare-related services.

The company has historically concentrated on the Greek and broader European healthcare markets while expanding internationally through acquisitions, licensing agreements, and strategic investments. Its portfolio includes proprietary nutraceutical brands such as Sky Premium Life and healthcare-related subsidiaries involved in pharmaceutical logistics and distribution. Cosmos Health evolved from a pharmaceutical distribution-focused enterprise into a broader healthcare platform emphasizing preventive health, wellness products, and technology-enabled healthcare services. The company is publicly traded on the Nasdaq Capital Market under the ticker COSM.

Business Operations

Cosmos Health operates through pharmaceutical distribution, nutraceutical manufacturing and branding, healthcare services, and technology-enabled healthcare initiatives. Its operations include wholesale pharmaceutical distribution to pharmacies and healthcare providers, development and commercialization of nutraceutical products, and participation in healthcare software and telehealth-related activities. Key business units and subsidiaries include Sky Premium Life, Cosmos Holdings, and affiliated pharmaceutical distribution entities operating in Europe. The company’s nutraceutical products are marketed across multiple jurisdictions and distributed through pharmacies, retail channels, and e-commerce platforms.

The company maintains both domestic and international operations, with a strong operational footprint in Greece and broader activities across Europe and selected international markets. Cosmos Health has pursued operational control over distribution networks, inventory management capabilities, and branded product intellectual property to strengthen vertical integration. The company has also entered partnerships involving healthcare technologies, pharmaceutical supply chains, and product commercialization arrangements intended to support cross-border expansion and broader healthcare market penetration.

Strategic Position & Investments

Cosmos Health’s strategic direction has focused on expanding its proprietary wellness and nutraceutical portfolio while strengthening pharmaceutical distribution capabilities and healthcare technology investments. Growth initiatives have included acquisitions, strategic share investments, international product distribution agreements, and efforts to diversify revenue beyond traditional pharmaceutical wholesale activities. The company has publicly emphasized preventive healthcare, wellness-oriented products, and technology integration as core long-term themes.

The company has completed acquisitions and investments involving healthcare distribution businesses and nutraceutical assets, including the expansion of Sky Premium Life branded operations. Cosmos Health has also explored emerging sectors such as telehealth, healthcare software, and artificial intelligence-enabled healthcare applications through partnerships and investment activity. Public filings and corporate disclosures indicate continued interest in scalable healthcare infrastructure, international distribution channels, and technology-driven healthcare solutions. Certain investment initiatives and strategic outcomes remain subject to evolving market conditions and regulatory approvals.

Geographic Footprint

Cosmos Health is headquartered in Chicago, Illinois, with substantial operational activity centered in Greece and additional commercial reach across Europe. The company distributes products internationally through wholesale channels, pharmacies, retail partners, and online platforms. Its operational structure reflects a combination of U.S.-based corporate management and European pharmaceutical distribution infrastructure.

The company’s market presence includes activities in North America, Europe, and selected international markets where its nutraceutical and wellness products are sold. International operations have been supported through subsidiaries, licensing arrangements, and cross-border distribution relationships. Cosmos Health has continued pursuing broader international visibility through Nasdaq market participation, healthcare investments, and expansion of branded consumer health products into new geographic regions.

Leadership & Governance

Cosmos Health is led by a management team with experience in pharmaceuticals, healthcare distribution, finance, and international business development. The company’s leadership strategy has emphasized diversification, international expansion, vertical integration, and the development of proprietary healthcare and wellness brands. Public corporate communications and SEC filings indicate a strategic focus on operational scalability, healthcare innovation, and strengthening shareholder value through acquisitions and market expansion initiatives.

Key executives include:

• Grigorios Siokas – Chief Executive Officer
• Grigorios Lampropoulos – Chief Financial Officer
• Michael Kakolyris – Executive Vice President and Director
• Ioannis Zotos – Senior operational executive associated with pharmaceutical distribution activities

Corporate governance is overseen by the company’s board of directors and executive leadership in accordance with Nasdaq listing standards and applicable U.S. securities regulations. Information regarding executive roles, governance structure, and operational strategy has been disclosed through company filings, investor communications, and public regulatory documents.